Hereditary neuropathic amyloidosis is a progressive genetic disorder where abnormal protein deposits gradually accumulate in the body’s organs and tissues, particularly affecting the nervous system, heart, and other vital organs. This condition, passed down through families, can profoundly alter daily life as symptoms slowly emerge and worsen over time.

Understanding the Global Impact

Hereditary neuropathic amyloidosis, also known as hereditary transthyretin (ATTRv) amyloidosis, affects people around the world, though its frequency varies considerably by region and ethnic background. The exact number of people living with this condition remains uncertain, but researchers believe it may be more common than previously thought and is currently underdiagnosed.^[6]

In certain areas of the world, this condition appears more frequently. In northern Portugal, for example, approximately one in 538 people may develop hereditary neuropathic amyloidosis. Among Americans of European descent, the condition is less common, affecting an estimated one in 100,000 people. The disease shows different patterns across various populations. People of African descent, particularly African Americans, face a higher risk of developing certain forms of the condition, with about 3 to 4 percent of African Americans carrying a specific genetic change that can lead to the disease. In some West African regions, this percentage may reach approximately 5 percent.^[2]

The condition tends to manifest at different ages depending on geographic origin and genetic background. In areas where the disease is more common, such as parts of Portugal and Japan, symptoms typically begin to appear when people reach their third to fifth decade of life, meaning roughly between ages 30 and 50. In other parts of the world, the disease often starts later in life.^[1] Not everyone who inherits the genetic mutation will develop symptoms, which adds another layer of complexity to understanding who will be affected and when.^[6]

What Causes This Condition

Hereditary neuropathic amyloidosis develops because of changes in a specific gene called the TTR gene. This gene provides instructions for making a protein called transthyretin, which normally circulates in the bloodstream carrying vitamin A and thyroid hormones throughout the body. The liver is the primary organ responsible for producing this protein.^[2]

When mutations occur in the TTR gene, the transthyretin protein becomes unstable. Instead of maintaining its normal structure, these abnormal proteins break apart and fold incorrectly. These misfolded proteins then clump together to form deposits called amyloid fibrils. Over time, these protein clumps accumulate in various organs and tissues, causing damage and disrupting normal function.^[3]

Scientists have identified more than 120 different mutations in the TTR gene, and research continues to uncover additional variants. Each specific mutation can lead to different patterns of disease, affecting when symptoms start, which organs are primarily involved, and how rapidly the condition progresses. Some of the most commonly identified mutations include the V30M variant, found predominantly in Portugal, Spain, France, Sweden, Japan, and among descendants from these regions. The V122I variant appears in approximately 3 to 4 percent of African Americans, while the T60A variant is more common among people of Irish descent and is the most frequently seen variant in the United Kingdom.^[7][9]

Who Is at Risk

The primary risk factor for developing hereditary neuropathic amyloidosis is having a family history of the condition. Because this is an inherited disorder, children of affected parents face a 50 percent chance of inheriting the genetic mutation. Family members of people with the condition should consider genetic testing and monitoring, even if they feel perfectly healthy.^[12]

Ancestry and ethnic background play significant roles in determining risk. Black individuals, particularly those of African American descent, face increased likelihood of carrying certain TTR gene mutations. People with Portuguese, Japanese, Swedish, Spanish, French, or Irish heritage may also have elevated risk for specific variants of the condition.^[9]

Age represents another important consideration. While people are born with the genetic mutation, symptoms typically do not appear until adulthood. The age of symptom onset varies widely, generally ranging from the 20s to the 70s, depending on the specific genetic variant and other factors that researchers do not yet fully understand.^[2]

Gender may influence risk for certain manifestations of the disease. Some research suggests that males, particularly those over 65 years old, appear more likely to develop certain forms of the condition, though both men and women can be affected.^[6]

Recognizing the Symptoms

Hereditary neuropathic amyloidosis causes a wide range of symptoms because amyloid deposits can accumulate in multiple organs and tissues. The symptoms a person experiences depend largely on which organs are affected and how extensively the protein deposits have damaged them. Many symptoms develop gradually and may initially seem unrelated to each other, which can make diagnosis challenging.^[3]

Damage to the peripheral nervous system, which includes nerves connecting the brain and spinal cord to the rest of the body, often produces the earliest and most prominent symptoms. Many people first notice unusual sensations in their feet, such as tingling, numbness, or a pins-and-needles feeling. These sensations typically start in the lower extremities and gradually spread upward. Over time, the loss of sensation can extend to the hands. As the condition progresses, motor function becomes affected, leading to muscle weakness that makes walking difficult and can cause frequent falls.^[4]

The autonomic nervous system, which controls involuntary body functions, is frequently damaged in hereditary neuropathic amyloidosis. This can lead to a sudden drop in blood pressure when standing up, a condition called orthostatic hypotension that causes dizziness or lightheadedness. Digestive problems are common and may include alternating constipation and diarrhea, attacks of nausea and vomiting, delayed stomach emptying, and unintentional weight loss. Sexual function may be impaired, with men experiencing erectile dysfunction. Other autonomic symptoms include reduced or absent sweating, and problems with urination such as retention or incontinence.^[1][14]

When amyloid deposits accumulate in the heart, they cause the heart muscle to thicken and become stiff, a condition known as restrictive cardiomyopathy. This makes it harder for the heart to pump blood effectively throughout the body. People with cardiac involvement may experience shortness of breath, especially during physical activity or even at rest in more severe cases. Ankle and leg swelling due to fluid buildup is common. The heart may beat irregularly or too fast, causing palpitations. Some people experience chest pain, extreme fatigue, or fainting spells. These symptoms can progressively worsen and lead to heart failure.^[6][7]

Eye problems occur frequently in hereditary neuropathic amyloidosis. Many people develop cloudy areas in the clear gel that fills the eyeball, causing spots or floaters in their vision. Dry eyes are common and can be uncomfortable. Some individuals develop glaucoma, which is increased pressure inside the eye that can damage vision if left untreated. In some cases, the pupils may appear irregular or have a scalloped appearance.^[2]

Kidney involvement can range from mild to severe. Some people develop protein in their urine or experience changes in how their kidneys function. In more advanced cases, kidney disease can progress to the point where dialysis becomes necessary.^[1]

Carpal tunnel syndrome, characterized by numbness, tingling, and weakness in the hands and fingers, often appears as an early symptom. This occurs when amyloid deposits put pressure on the nerve that runs through the wrist. Many people have difficulty gripping objects or performing fine motor tasks like buttoning clothing.^[3][17]

Less commonly, the disease can affect the central nervous system, including the brain and spinal cord. When this happens, people may experience stroke-like symptoms, bleeding in the brain, accumulation of fluid in the brain, difficulty coordinating movements, muscle stiffness and weakness, seizures, or loss of intellectual function.^[2]

Preventing and Detecting the Disease Early

Because hereditary neuropathic amyloidosis results from genetic mutations, there is currently no way to prevent the condition from developing in someone who has inherited the abnormal gene. However, early detection and monitoring can make a significant difference in managing the disease and potentially slowing its progression.^[8]

For individuals who have a family history of hereditary neuropathic amyloidosis, genetic testing offers the opportunity to learn whether they carry a TTR gene mutation. This testing involves a simple blood sample that can identify specific mutations in the TTR gene. Knowing one’s genetic status allows for early monitoring and intervention if symptoms begin to appear. Healthcare providers often recommend that family members of affected individuals consider genetic testing, though this is a personal decision that may benefit from discussion with a genetic counselor.^[9]

People who know they carry a TTR mutation but have not yet developed symptoms should undergo regular monitoring. Recommended assessments typically include neurological examinations to check for early signs of nerve damage, heart evaluations to detect cardiac involvement before symptoms appear, eye examinations, and kidney function tests. The frequency of these assessments varies but often occurs every six to twelve months. This proactive approach allows healthcare providers to detect the earliest signs of disease and begin treatment promptly, which may help preserve function and quality of life.^[12]

Family planning represents another important consideration for individuals who carry TTR mutations. Genetic counseling can help prospective parents understand the risks of passing the condition to their children and discuss available reproductive options.^[1]

How the Disease Affects the Body

Understanding what happens inside the body when hereditary neuropathic amyloidosis develops helps explain why symptoms appear and progress the way they do. The fundamental problem begins with the unstable transthyretin protein. Under normal circumstances, transthyretin molecules join together to form a stable structure made of four protein units called a tetramer. This structure allows the protein to safely carry vitamin A and thyroid hormones through the bloodstream.^[2]

When mutations affect the TTR gene, the resulting transthyretin proteins do not form stable tetramers. These unstable structures break apart more easily, and the individual protein molecules then misfold. Instead of maintaining the shape necessary for their normal function, they twist and fold incorrectly. These misfolded proteins stick together, forming long, rigid fibers called amyloid fibrils. These fibrils are insoluble, meaning they cannot dissolve in body fluids, so they accumulate wherever they are deposited.^[3]

The blood carries these amyloid fibrils throughout the body, and they gradually accumulate in various tissues and organs. The deposits physically interfere with normal organ structure and function. In nerves, amyloid accumulation disrupts the transmission of signals. Small nerve fibers, which carry information about pain, temperature, and autonomic functions, are typically affected first. This explains why early symptoms often include altered sensation and autonomic dysfunction. As the disease progresses, larger nerve fibers become involved, leading to more extensive sensory loss and motor weakness.^[4]

In the heart, amyloid deposits infiltrate the muscle tissue, causing the walls to thicken and become rigid. This stiffening prevents the heart from relaxing properly between beats, which reduces its ability to fill with blood. As a result, less blood is pumped with each heartbeat, and fluid begins to back up in the body, causing swelling and shortness of breath. The deposits can also disrupt the heart’s electrical system, leading to rhythm disturbances.^[6]

In the digestive system, amyloid accumulation in the nerves that control gut movement and secretion leads to problems with motility and digestion. The stomach may empty more slowly than normal, and the intestines may not move food along properly, resulting in the nausea, vomiting, and alternating diarrhea and constipation that many people experience.^[14]

The eyes are affected when amyloid deposits accumulate in the vitreous, the clear gel inside the eye, causing cloudiness and visual disturbances. Deposits in the structures that drain fluid from the eye can lead to increased pressure and glaucoma.^[1]

The kidneys filter the blood, and when amyloid deposits accumulate in the filtering units, kidney function declines. Protein may leak into the urine, and waste products begin to accumulate in the blood as the kidneys become less efficient.^[1]

The progressive nature of the disease reflects the continuing production of abnormal transthyretin protein and the ongoing accumulation of amyloid deposits over time. Once formed, these deposits are difficult for the body to break down and remove, so they persist and grow larger as more amyloid is added. This explains why symptoms typically worsen gradually rather than remaining stable.^[8]